Medigus Ltd. (NASDAQ:MDGS) Short Interest Down 81.1% in January
Medigus Ltd. (NASDAQ:MDGS) Short Interest Down 81.1% in January
Medigus Ltd. (NASDAQ:MDGS – Get Rating) saw a large decline in short interest in January. As of January 15th, there was short interest totalling 5,100 shares, a decline of 81.1% from the December 31st total of 27,000 shares. Based on an average daily volume of 33,600 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.9% of the shares of the company are short sold.
梅迪格斯有限公司（NASDAQ：千年發展目標-獲取評級）在一月份看到了短期利益大幅下降。截至 1 月 15 日，總共有 5,100 股短息，較十二月三十一日共 27,000 股股份下降 81.1%。根據每日平均成交量為 33,600 股，日數佔覆蓋率目前為 0.2 天。目前，該公司股份的 0.9％ 賣空。
Medigus Trading Down 3.9 %
醫療交易下降 3.9%
Shares of MDGS stock traded down $0.20 during midday trading on Monday, reaching $4.87. 4,600 shares of the company traded hands, compared to its average volume of 12,211. The firm's 50 day simple moving average is $5.89 and its two-hundred day simple moving average is $7.62. Medigus has a 1-year low of $4.45 and a 1-year high of $19.50. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.39 and a quick ratio of 1.33.
週一中午交易期間，千年發展目標股票的股價下跌 0.20 美元，達到 4.87 美元。4,600 股的手，相比其平均交易量為 12,211。該公司的 50 天簡單移動平均線為 5.89 美元，其 200 日簡單移動平均線為 7.62 美元。米迪格斯有一年低點 4.45 美元和 1 年高點 19.50 美元。該公司的債務與權益比率為 0.11，流動比率為 1.39，快速比率為 1.33。
Medigus Dividend Announcement
醫療股息公告
The business also recently declared a dividend, which was paid on Wednesday, December 28th. Stockholders of record on Tuesday, December 20th were given a dividend of $0.85 per share. The ex-dividend date was Monday, December 19th. This represents a dividend yield of 12.9%.
該業務最近還宣布了股息，該股息於 12 月 28 日星期三支付。12 月 20 日（星期二）的記錄股東獲得每股 0.85 美元的股息。除息日期為 12 月 19 日星期一。這代表了 12.9％ 的股息收益率。
Institutional Investors Weigh In On Medigus
機構投資者權衡醫療
About Medigus
關於麥迪格斯
(Get Rating)
(取得評分)
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities.
Medigus Ltd. 是一家以技術為基礎的公司，在美國、歐洲、中國、以色列和國際上提供醫療相關設備和產品。它提供 Medigus 超聲外科內窺鏡，一種內窺鏡檢查系統，用於治療胃食管反流疾病。該公司還開發生物凝膠，以保護患者免受生物威脅，並減少過敏原和病毒通過上呼吸道和眼腔的侵入。
Read More
閱讀更多
- Get a free copy of the StockNews.com research report on Medigus (MDGS)
- 4 High-Yield Dividend Kings For 2023
- Will 2023 be a Good Year for Goodyear Tire Stock?
- Lululemon Stock, Buying Opportunity on Lowered Guidance?
- Is Delta On Track To Hit A Fresh 52-Week High?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 免費獲取有關麥迪格斯研究報告的副本
- 4 2023 年的高收益股息國王
- 2023 會成為固特異輪胎庫存的好年份嗎？
- 露露檸檬股票, 在降低指導購買機會?
- 三角洲正在追求 52 周新高嗎？
- 您應該將這些沃倫·巴菲特股票添加到您的投資組合中嗎？
Receive News & Ratings for Medigus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medigus and related companies with MarketBeat.com's FREE daily email newsletter.
接收《醫療日報》的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件時事通訊接收 Medigus 和相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。